Evaluation of Physiologically Based Pharmacokinetic Models in Risk Assessment: An Example with Perchloroethylene

By Clewell Harvey   Gentry P.   Kester Janet   Andersen Melvin  

Critical Reviews in Toxicology, Vol. 35, Iss. 5, 2005-06 ,pp. : 413-433

Informa Healthcare

Access to resources Recommend Favorite

Development of a Physiologically Based Pharmacokinetic Model for Hydroquinone

By Corley R.A.   English J.C.   Hill T.S.   Fiorica L.A.   Morgott D.A.  

Toxicology and Applied Pharmacology, Vol. 165, Iss. 2, 2000-06 ,pp. : 163-174

Elsevier

Access to resources Recommend Favorite

Summary of panel discussion on the 'advantages/limitations/uncertainties in the use of physiologically based pharmacokinetic and pharmacodynamic models in hazard identification and risk assessment of toxic substances'

By Frederick C.B.  

Toxicology Letters, Vol. 79, Iss. 1, 1995-09 ,pp. : 201-206

Elsevier

Access to resources Recommend Favorite

Using Physiologically-Based Pharmacokinetic Models to Incorporate Chemical and Non-Chemical Stressors into Cumulative Risk Assessment: A Case Study of Pesticide Exposures

By Wason Susan C.   Smith Thomas J.   Perry Melissa J.   Levy Jonathan I.  

International Journal of Environmental Research and Public Health, Vol. 9, Iss. 5, 2012-05 ,pp. : 1971-1983

MDPI

Access to resources Recommend Favorite

The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substances

By Clewell H.J.  

Toxicology Letters, Vol. 79, Iss. 1, 1995-09 ,pp. : 207-217

Elsevier

Access to resources Recommend Favorite